| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2002 | EP1012151B1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders |
| 08/07/2002 | EP1007094B1 Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying |
| 08/07/2002 | EP1003508A4 Antimutagenic agents |
| 08/07/2002 | EP0986562B1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 08/07/2002 | EP0986537B1 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 08/07/2002 | EP0983259B1 Tocopherol esters and their cosmetic and pharmaceutical uses |
| 08/07/2002 | EP0981330B1 Topical compositions |
| 08/07/2002 | EP0980379B1 Chimeric oligonucleotides and the use thereof |
| 08/07/2002 | EP0971695A4 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 08/07/2002 | EP0912097B1 Antimicrobial peroxidase compositions |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/07/2002 | EP0885239B1 Novel steroid carbamates as potentiating agents |
| 08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
| 08/07/2002 | EP0839143B1 Tetralin compounds with mdr activity |
| 08/07/2002 | EP0831856B1 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 08/07/2002 | EP0828478B1 Osmotic device with delayed activation of drug delivery and complete drug release |
| 08/07/2002 | EP0825869B1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 08/07/2002 | EP0817615B1 Peroral composition for controlled release in the lower gastrointestinal tract |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | EP0777457B1 Use of glyceryl triacetate for treating onychomycoses |
| 08/07/2002 | EP0764023B1 Compounds and compositions for administration via oral inhalation or insufflation |
| 08/07/2002 | EP0748217B1 Compositions comprising a mast cell degranulation-blocking h-1 receptor antagonist for the treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| 08/07/2002 | EP0727996B1 Fenbendazole formulations |
| 08/07/2002 | EP0701434B1 Preparations containing silicon dioxide to improve the taste thereof |
| 08/07/2002 | EP0689434B1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 08/07/2002 | CN1362969A Antimicrobial/endotoxin neutralizing polypeptide |
| 08/07/2002 | CN1362964A Novel 8A-and 9A-15-membered lactams |
| 08/07/2002 | CN1362963A 3-deoxy-desmycosin derivatives and process for their preparation |
| 08/07/2002 | CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 08/07/2002 | CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362958A C7 carbonate substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362955A C7 ester substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362949A 1,5-benzodiazepine derivatives as cck-A receptor agonists |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362884A Preventives/remedies for liver diseases |
| 08/07/2002 | CN1362882A Use of catechin for preventing or treaitng coronary restenosts |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362879A Patches containing buprenorphine hydrochloride |
| 08/07/2002 | CN1362878A Pharmaceutical preparation containing the active substance heroin and its utilization in a method for treating opiate addiction |
| 08/07/2002 | CN1362877A Method for treating neurodegeneration |
| 08/07/2002 | CN1362876A C10 heterosubstituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1362875A Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 08/07/2002 | CN1362860A Low-molecular weight polymannuronate |
| 08/07/2002 | CN1362419A Schizophyllum tetrasaccharide-alkyl glycoside compound and its prepn and application |
| 08/07/2002 | CN1362409A 2-phenoxy pyrimidine derivative and its use in treating disease |
| 08/07/2002 | CN1362407A Glutarimide compound S632A3 and its prepn and application in preparing medicine for treating viral infection and tumor |
| 08/07/2002 | CN1362406A Method for producing one or more kinds of oxydic carotenoid dry powder |
| 08/07/2002 | CN1362260A Medicine for treating anal disease and its prepn. |
| 08/07/2002 | CN1362256A Osteological Chinese medicine prepn. |
| 08/07/2002 | CN1362067A Bee glue prepn for treating stomatocase and its compounding process |
| 08/07/2002 | CN1362064A Antineoplastic composite and its prepn process and use |
| 08/07/2002 | CN1362063A Nanometer polyporus umbrellatus polysaccharide medicine prepn and its prepn process |
| 08/07/2002 | CN1362062A Mixed veterinary parasiticide prepn containing albendazole and chlorocyaniosaliamine |
| 08/07/2002 | CN1362061A New medicine use of 6-methoxy-2-delta 10'-cis-heptadecene-1,4 benzoquinone |
| 08/07/2002 | CN1362060A Prepn of nano hydroxycamptothecine-dextran grain |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/07/2002 | CN1088708C Amidine derivatives useful as anti-platelet aggreaction inhibitors and vasodilators and their use |
| 08/07/2002 | CN1088707C 2-carbonylthiazole derivatives and use of the same |
| 08/07/2002 | CN1088706C Novel heterocyclic amide compounds and medicinal uses thereof |
| 08/07/2002 | CN1088703C Water soluble of taxad alcohol derivative |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/07/2002 | CN1088698C Micro-particulate form of tetrahydropyridin derivatives |
| 08/07/2002 | CN1088600C Use of bruffen-beta-cyclodextrin matches |
| 08/07/2002 | CN1088591C Medicine for curing and preventing upper respiratory infection and stopping-smoking, and its preparing method |
| 08/07/2002 | CN1088588C Chemotherapeutic compositions |
| 08/07/2002 | CN1088587C Topical anti-inflammatory compositions containing piroxican |
| 08/07/2002 | CN1088586C Interleukin-1 inhibitor |
| 08/07/2002 | CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases |
| 08/07/2002 | CN1088582C Lipid-based carriers which can treat multiple diseases and have layered lipid componnets, their composition and use |
| 08/07/2002 | CN1088579C Antiplague oral composition |
| 08/06/2002 | US6429328 Processes and intermediate compounds for preparing guanidine and amidine derivatives |
| 08/06/2002 | US6429320 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6429315 Process for preparing N6-substituted adenosine derivatives |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6429275 Functionalized silicon compounds and methods for their synthesis and use |
| 08/06/2002 | US6429232 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/06/2002 | US6429230 Treating chronic uremic patients undergoing periodical dialysis |
| 08/06/2002 | US6429229 Keto acid salts and amine derivatives, and their use for preparing medicines |
| 08/06/2002 | US6429228 Local anesthetic for external use |
| 08/06/2002 | US6429227 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/06/2002 | US6429226 Prostaglandin derivatives with phenyl ring in omega chain; topical application |
| 08/06/2002 | US6429225 For use in therapy of chronic gastritis and gastric ulcer |
| 08/06/2002 | US6429224 Use of taurolidine to treat tumors |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429222 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/06/2002 | US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication |
| 08/06/2002 | US6429219 Administering to treat glaucoma, diabetes, macular degeneration, neurodegenerative diseases and vasoconstriction |
| 08/06/2002 | US6429218 Applying a serum, cream, or lotion containing extra niacin to treat skin disorders such as acne, blackheads, fine lines, and enlarged pores; concentration is sufficient to produce warmth, blush, flushing or redness of skin |